Genenta Science S.P.A.

Genenta Science S.P.A., a clinical-stage biotechnology company, is making significant strides in cancer treatment with its innovative lentivirus-based gene and cell therapies, positioning it for future growth and success in the healthcare industry.

Genenta Science S.P.A. is a pioneering biotechnology company leading the development of innovative gene and cell therapies for cancer treatment, with a strong focus on precision and personalized medicine.